Side-by-side comparison of AI visibility scores, market position, and capabilities
NYC residential sale-leaseback fintech permanently closed December 2024; $127M raised ($28M Northwestern Mutual Series D Feb 2024) before state AG enforcement actions in Michigan/Massachusetts and consumer lawsuits across 5 states led to closure.
EasyKnock was a New York City-based residential sale-leaseback fintech company — having raised $127 million in total venture funding over 9 rounds including a $28 million Series D led by Northwestern Mutual in February 2024 — that permanently closed in December 2024 following regulatory enforcement actions and consumer litigation. Founded in 2016 by CEO Jarred Kessler and Ben Black, EasyKnock pioneered the residential sale-leaseback model in the United States, allowing homeowners to sell their property to EasyKnock for immediate liquidity while remaining as tenants in their home — targeting homeowners seeking to access equity without moving, those facing potential foreclosure, or property owners seeking capital for investments.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.